GJC1 and acute myeloid leukemia: This study demonstrated that all investigated connexins (i.e., Cx26, Cx32, Cx37, Cx43 and Cx45) were expressed in AML cells, but detectable expression for >40% of the patients was observed only for Cx43 (42%) and Cx45 (55%), even though these two connexins showed the lowest mRNA expression.